In the US, Omalizumab (omalizumab systemic) is a member of the drug class other immunosuppressants and is used to treat Asthma, Maintenance.
US matches:
- Omalizumab
- Omalizumab Subcutaneous
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
R03DX05
CAS registry number (Chemical Abstracts Service)
0242138-07-4
Chemical Formula
C6450-H9916-N1714-O2023-S38
Molecular Weight
145058
Therapeutic Categories
Antiasthmatic agent
Antiallergic agent
Immunomodulator
Chemical Name
Immunoglobulin G, anti-(human immunoglobulin E Fc region) (human-mouse monoclonal E25 clone psVIE26 gamma-chain), disulfide with human-mouse monoclonal E25 clone psVIE26 *k63-chain, dimer (WHO)
Foreign Names
- Omalizumabum (Latin)
- Omalizumab (German)
- Omalizumab (French)
- Omalizumab (Spanish)
Generic Names
- Omalizumab (OS: BAN, USAN)
- AL 901 (IS)
- anti-Ig E (IS)
- CGP 51901 (IS)
- E25 (IS)
- Humanized anti-IgE monoclonal antibody (IS)
- IGE 025 (IS)
- Monoclonal antibody E25 (IS)
- Monoklonaler Anti-Ig E Antikörper, human, rekombiniert (IS)
- Monoklonaler Antikörper E25 (IS)
- Olizumab (IS)
- psVIE26 *k63-chain, dimer (IS: WHO)
- Recombinant humanized anti-IgE monoclonal antibody (IS)
- rhu MAb-E25 (IS)
- TNX 901 (IS)
Brand Names
- Xolair
Genentech, United States; Novartis, Argentina; Novartis, Australia; Novartis, Belgium; Novartis, Brazil; Novartis, Canada; Novartis, Switzerland; Novartis, Czech Republic; Novartis, Germany; Novartis, Spain; Novartis, Finland; Novartis, France; Novartis, United Kingdom; Novartis, Hong Kong; Novartis, Croatia (Hrvatska); Novartis, Hungary; Novartis, Ireland; Novartis, Israel; Novartis, Japan; Novartis, Mexico; Novartis, Netherlands; Novartis, Norway; Novartis, New Zealand; Novartis, Poland; Novartis, Portugal; Novartis, Sweden; Novartis, Singapore; Novartis, Slovenia; Novartis, Slovakia; Novartis, Turkey; Novartis, Venezuela; Novartis Europharm, Austria; Novartis Europharm Ltd., Denmark
International Drug Name Search
Glossary
| BAN | British Approved Name |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
| WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment